Eli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging demand for its GLP-1 weight-loss drugs. on.wsj.com/4clxdRn
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
Eli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging demand for its GLP-1 weight-loss drugs.
on.wsj.com